|
Sales
table
Lowered
Full-Year 2026
|
Full-Year 2026 |
$20B – $20.1B |
—
|
|
Organic Growth
table
Raised
Full-Year 2026
|
Full-Year 2026 |
4% – 5% |
Non-GAAP
|
|
Segment Margin
table
Lowered
Full-Year 2026
|
Full-Year 2026 |
20.5% |
Non-GAAP
|
|
Adjusted Earnings Growth
table
Raised
Full-Year 2026
|
Full-Year 2026 |
30% – 31% |
Non-GAAP
|
|
Operating Cash Flow
table
Full-Year 2026
|
Full-Year 2026 |
$2.1B |
—
|
|
Free Cash Flow
table
Lowered
Full-Year 2026
|
Full-Year 2026 |
$2.1B |
Non-GAAP
|
|
Earnings per share of common stock from continuing operations -
table
Raised
Twelve Months Ended December 31, 2026(E)
|
Twelve Months Ended December 31, 2026(E) |
$21.88 – $21.93 |
GAAP
|
|
Adjusted earnings per share of common stock from continuing oper
table
Lowered
For the twelve months ended December 31, 2026
|
For the twelve months ended December 31, 2026 |
$8.40 – $8.45 |
Non-GAAP
|
|
Expected adjustment for acquisition-related intangibles amortiza
For the twelve months ended December 31, 2026
|
For the twelve months ended December 31, 2026 |
$382M |
—
|
|
Expected adjustment for acquisition-related costs
For the twelve months ended December 31, 2026
|
For the twelve months ended December 31, 2026 |
$39M |
—
|
|
Expected adjustment for debt restructuring costs excluding spin-
For the twelve months ended December 31, 2026
|
For the twelve months ended December 31, 2026 |
$228M |
—
|
|
Expected adjustment for ERP implementation costs
For the twelve months ended December 31, 2026
|
For the twelve months ended December 31, 2026 |
$26M |
—
|
|
Expected impairment charge of assets held for sale
For the twelve months ended December 31, 2026
|
For the twelve months ended December 31, 2026 |
$236M |
—
|
|
Expected gain on sale of personal protection equipment business
For the twelve months ended December 31, 2026
|
For the twelve months ended December 31, 2026 |
$221M |
—
|
|
Expected adjustment for the impact of the Russia-Ukraine conflic
For the twelve months ended December 31, 2026
|
For the twelve months ended December 31, 2026 |
$6M |
—
|
|
Expected net income adjustment for Quantinuum
For the twelve months ended December 31, 2026
|
For the twelve months ended December 31, 2026 |
$107M |
—
|